The Penn Center for Cancer Care Innovation is thrilled to announce that PC3I Fellow Anna Jo Smith, MD, MPH, MSc has earned a Young Investigator Award from Conquer Cancer, the ASCO Foundation. The award provides funding to promising investigators as they transition from fellows to faculty.
Dr. Smith will focus on improving care delivery for patients with adnexal masses and suspected ovarian cancer. Ovarian cancer is among the deadliest of gynecologic cancers and currently lacks effective screening. While survival improves with surgical evaluation by a gynecologic oncologist, chemotherapy, and/or targeted cancer drugs called PARP inhibitors, many patients do not receive these treatments. Therefore, to increase patient participation in the previously mentioned treatments and reduce care disparities that start at diagnosis, Dr. Smith is testing the implementation of a default clinician-directed opt-out nudge to improve referral to gynecologic oncology for patients with suspected ovarian cancer, with a particular focus on patients from historically marginalized populations. The study will be conducted over a 12-month period and will examine the effect of clinician nudges compared with usual care.
Through the Innovation Accelerator, the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center (ACC) invite applications for initiatives that aim to create and test innovative solutions to address challenges in productivity, efficiency, clinician wellbeing, or access in cancer care at Penn Medicine
Research led by PC3I Faculty Emily Ko showed that implementing telehealth into clinical trials is both safe and feasible.
PC3I Faculty, Fellows, and Staff present 17 abstracts at the 2023 ASCO Quality Care Symposium in Boston, MA.